ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0467

Lung Involvement in Early Rheumatoid Arthritis, Analysis of ERA UCLouvain Brussels FINDRA Cohort

FROIDURE Antoine1, DOYEN Marie2, PERROT Marie1, GHAYE Benoit3, SAPART Emilie4, BEARZATTO Bertrand5, DURANT Jean-François5, AMBROISE Jérôme5, GALA Jean-Luc5, ZAN Deniz3, AVRAMOVSKA Aleksandra4, SOKOLOVA Tatiana4, KOENIG Sandra2 and DUREZ Patrick4, 1Pulmonology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 2Rheumatology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 3Radiology department, Cliniques Universitaires Saint-Luc, Brussels, Belgium, 4Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Rheumatology, Brussels, Belgium, 5Institute de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint-Luc - Université Catholique de Louvain (UCL), Brussels, Belgium

Meeting: ACR Convergence 2024

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The prevalence of lung involvement in rheumatoid arthritis (RA) remains elusive. We set up a prospective study to detect ILD, bronchiolitis and nodules in early RA.

Methods: The Factors of ILD in Newly Diagnosed RA (FINDRA, NCT04002765) study is a prospective multicentric trial. We proposed inclusion to patients with a newly diagnosed RA according to ACR/EULAR criteria and defined early disease as symptoms present for at least 1 year and maximum 10 years. After informed consent, patients underwent full respiratory evaluation consisting of an environmental questionnaire, HRCT, pulmonary function tests (PFT) and sampling for genetic analysis of common variants associated with RA-ILD. HRCT were centrally reviewed for the presence of ILD (primary outcome), expiratory trapping and nodules (secondary outcomes).

Results: We screened290 patients and excluded 32 who did not undergo the requested exams (N=30) or had a RA diagnosis older than 10 years (N=2). The median age of the 258 included patients was 56 years-old. The majority (71%) were female, 48% were ex- or current smokers. 71% had a positive rheumatoid factor and 67% positive anti-citrullinated peptides antibodies. The majority ware treated with methotrexate (77%) and/or another DMARD (50%).

We detected ILD in 38 patients (15%), emphysema in 51 (20%) and bronchiolitis in 89 (41%). Older age, male sex, disease activity and low diffusion capacity (DLCO) were associated with ILD; older age, male sex, smoking status and low DLCO were associated with emphysema. Finally, neither of the variables associated with air trapping.

Conclusion: In this multicentric prospective study with HRCT central review, lung involvement affected a high proportion of RA patients, bronchiolitis being the most prevalent, followed by emphysema and ILD. Old age and male sex were associated with both ILD and emphysema, suggesting that we should prioritize screening in this population. Analysis with genetic testings are ongoing.  


Disclosures: F. Antoine: None; D. Marie: None; P. Marie: None; G. Benoit: None; S. Emilie: None; B. Bertrand: None; D. Jean-François: None; A. Jérôme: None; G. Jean-Luc: None; Z. Deniz: None; A. Aleksandra: None; S. Tatiana: None; K. Sandra: None; D. Patrick: None.

To cite this abstract in AMA style:

Antoine F, Marie D, Marie P, Benoit G, Emilie S, Bertrand B, Jean-François D, Jérôme A, Jean-Luc G, Deniz Z, Aleksandra A, Tatiana S, Sandra K, Patrick D. Lung Involvement in Early Rheumatoid Arthritis, Analysis of ERA UCLouvain Brussels FINDRA Cohort [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/lung-involvement-in-early-rheumatoid-arthritis-analysis-of-era-uclouvain-brussels-findra-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lung-involvement-in-early-rheumatoid-arthritis-analysis-of-era-uclouvain-brussels-findra-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology